Endorsements

The following individuals “share the goals of the Optimal Cancer Care Alliance and believe it is a clinical, financial, and ethical imperative to replace current oncology overdosing with optimal dosing. The right amount of medication at the right time reduces toxic side effects, provides the best clinical outcomes and lowers costs.”

	First Name	Last Name	Title/Position	Institutional Affiliation
Dr.	Ajay	Aggarwal		Institute of Cancer Policy, King's College, London
Dr.	Amol	Akhade		Nair Hospital, Mumbai
Dr.	Eitan	Amir	Medical Oncologist	Princess Margaret Cancer Centre
Dr.	Daniel	Araujo	Medical Oncologist	Hospital de Base, Sao Jose do Rio Preto
Dr.	Zeba	Aziz	Professor	Hameed Latif Hospital, Lahore, Pakistan
Dr.	Rajendra	Badwe	Director	Tata Memorial Centre
Dr.	David	Baer	Senior Oncologist	Kaiser Permanente
Dr.	Robert (Bob)	Bell	Professor Emeritus	University of Toronto
Dr.	Scott	Berry	Professor and Head	Department of Oncology, Queen's University
Dr.	Chris	Booth	Professor of Oncology	Queen's University
Dr.	Gauthier	Bouche		The Anticancer Fund
Dr.	Marc	Buyse	Chief Scientific Director	IDDI
Dr.	Emiliano	Calvo	Director, Clinical Research	START Madrid
Dr.	Kelvin	Chan	Medical Oncologist	Sunnybrook Cancer Centre
Dr.	Mark	Clemons	Medical Oncologist	The Ottawa Hospital
Dr.	Giovanni	Codacci-Pisanelli	Research Assistant	University of Rome "la Sapienza" Roma Italy
Dr.	Pippa	Corrie	Consultant Medical Oncologist	Cambridge University Hospitals NHS Foundation Trust
Dr.	Giuseppe	Curigliano	Professor	European Institute of Oncology
Dr.	Sarah	Danson	Professor of Medical Oncology	University of Sheffield, UK
Dr.	Grace	Dy	Chief Thoracic Oncology Medicine	Roswell Park Comprehensive Cancer Center
Dr.	Helena	Earl	Professor Emeritus	University of Cambridge, Dept of Oncology
Dr.	Lex	Eggermont	Chief Scientific Officer	Princess Maxima Center, Ultrecht University
Dr.	Makoto	Endo		Kyushu University Hospital
Dr.	Doreen	Ezeife	Medical Oncologist	Tom Baker Cancer Centre
Dr.	Doug	Figg	Senior Investigator	National Cancer Institute/NIH
Dr.	Varsha	Gandhi	Professor	MD Anderson Cancer Center
Dr.	Mark	Geraci	National PBM Clinical Pharmacy Program Manager	Dept of Veterans Affairs
Dr.	Ernesto	Gil Deza	Director of Education and Research	Instituto Henry Moore
Dr.	Silke	Gillesson	Professor	Oncology Institute of Southern Switzerland
Dr.	Boon-Cher	Goh	Professor	National University Cancer Institute, Singapore
Dr.	Yasushi	Goto		Nagasaki University Hospital
Dr.	Gwenaёlle	Gravis-Mescam		Institut Paoli-Calmettes Marseille France
Dr.	Alastair	Greystoke	Senior Lecturer	Newcastle University
Dr.	Ӧrvar	Gunnarsson	Medical Oncology	Landspitali, University Hospital, Iceland
Dr.	Bishal	Gyawali	Associate Professor	Queen's University
Dr.	Allan	Hackshaw	Professor, Director	Cancer Research UK & UCL Cancer Trials Centre
Dr.	Nazik	Hammad	Medical Oncologist	Queens University
Dr.	John	Hickman	Professor	University of Manchester
Dr.	Ian	Hirsch		Princess Margaret Cancer Centre
Dr.	Anthony	Joshua	Professor	Kinghorn Cancer Centre, St Vincents Hospital Sydney
Dr.	Michael	Kelley	Professor of Medicine	Duke University
Dr.	Jonathon	Kimmelman	Professor	McGill University / School of Population and Global Health
Dr.	Jenny	Ko	Medical Oncologist	BC Cancer - Abbotsford
Dr.	Hideo	Kunitoh		Japanese Red Cross Medical Center
Dr.	Ruth	Langley	Professor	MRC CTU at UCL
Dr.	Raya	Leibowitz	Head	Oncology Institute, Shamir Medical Center, Israel
Dr.	Lisa	Licitra	Professor	Fondazione IRCCS Istituto Nazionale dei Tumori
Dr.	Anne	Loeser	Founder	Patient-Centered Dosing Initiative
Dr.	Herbert	Loong	Associate Professor	The Chinese University of Hong Kong
Dr.	Indranil	Mallick	Senior Consultant Oncologist	Tata Medical Center, Kolkata
Dr.	Saroj	Niraula	Medical Oncologist	Cancer Care Manitoba
Dr.	Vanita	Noronha	Professor of Oncology	Tata Memorial Centre
Dr.	Takahiro	Osawa		Hokkaido University
Dr.	Leeza	Osiepenko	CEO, Dr	Consilium Scientific
Dr.	Max	Parmar	Professor	UCL
Dr.	Amol	Patel	Associate Professor	INHS ASVINI
Dr.	Cody	Peer	Clinical Pharmacologist	National Cancer Institute
Dr.	Franco	Perrone	Director Clinical Trial Unit	NCI, Naples Italy
Dr.	Martine	Piccart		Scientific Director, Institut Jules Bordet
Dr.	Ruth	Plummer	Professor of Experimental Cancer Medicine	Newcastle University, UK
Dr.	Gregory	Pond	Associate Professor	McMaster University
Dr.	Atik	Rahman	Director, DCPII	FDA
Dr.	Rachel	Riechelmann		A.C Camargo Cancer Center
Dr.	Gary	Rosner	Professor Emeritus	Johns Hopkins
Dr.	Everardo	Saad	Medical Director	IDDI
Dr.	Robbe	Saesen	Research Fellow	EORTC
Dr.	Tetsuo	Saito		Arao Municipal Hospital
Dr.	Martin	Schoen	Assistant Professor	St Louis University
Dr.	Peter	Selby	Emeritus Professor	University of Leeds
Dr.	Manju	Sengar	Professor	Tata Memorial Centre
Dr.	Lesley	Seymour		Director, IND Program, Deputy Director, CCTG, Professor, Queens University
Dr.	Matt	Seymour	Professor of Cancer Medicine	University of Leeds
Dr.	Lillian	Siu	Medical Oncologist	Princess Margaret Cancer Centre
Dr.	Gabe	Sonke	Professor	Netherlands Cancer Institute
Dr.	Walter	Stadler	Professor of Medicine	University of Chicago
Dr.	Anastasios	Stathis	Head-New Drugs Development Unit Chair-Clinical Research	Oncology Institute of Southern Switzerland-IOSI
Dr.	Martin	Stockler	Professor of Oncology and Clinical Epidemiology	NHRMC Clinical Trials Centre, University of Sydney
Dr.	Richard	Sullivan	Professor	Institute of Cancer Policy
Dr.	Chris	Sweeney	Professor, Director SAiGENCI – South Australian immunoGENomics Cancer Institute	The University of Adelaide
Dr.	Shinnosuke	Takemoto		Nagasaki University Hospital
Dr.	Winette	van der Graaf	Professor	Netherlands Cancer Institute
Dr.	Roger	von Moos	Professor	Medical Oncology, Cantonal Hospital Graubϋnden, Switzerland
Dr.	Jonathan	Wadsley	Professor	Weston Park Cancer Centre, Sheffield UK
Dr.	Lori	Wood	Medical Oncologist	Queen Elizabeth II Health Sciences Centre
Dr.	John	Zalcberg	Professor	Monash University

(Institutional affiliations are listed for identification purposes only)

Endorsements

ABOUT PERFECT

NAVIGATION

RECENT POSTS